[VISCO] March 2026 Revenue NT$348M (YoY +18.2%)

Key facts

  • [VISCO] March 2026 Revenue NT$348M (YoY +18.2%)
  • VISCO, a biotechnology and medical care company, announced that its monthly revenue for March 2026 reached NT$348 million, an 18.2% increase compared to the same month last year, indicating steady growth.
  • Source: PR Times
  • Date: March 1, 2026

Direct answer

VISCO, a biotechnology and medical care company, announced that its monthly revenue for March 2026 reached NT$348 million, an 18.2% increase compared to the same month last year, indicating steady growth.

Citation
[VISCO] March 2026 Revenue NT$348M (YoY +18.2%) (March 1, 2026), PR Times
Source
PR Times
Date
March 1, 2026
VISCO, a biotechnology and medical care company, announced that its monthly revenue for March 2026 reached NT$348 million, an 18.2% increase compared to the same month last year, indicating steady growth.
生技醫療業NQ 6/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
  • 🤖 AI Analyzed: April 12, 2026 at 21:31 (5h 1m after Collected)
Company Code: 4771
Company Name: VISCO
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 348,088 thousand NTD (NT$348 million)
Year-over-Year Change: +18.2%

FAQ

What are the key facts in this article?

VISCO, a biotechnology and medical care company, announced that its monthly revenue for March 2026 reached NT$348 million, an 18.2% increase compared to the same month last year, indicating steady growth.

What is the direct answer?

VISCO, a biotechnology and medical care company, announced that its monthly revenue for March 2026 reached NT$348 million, an 18.2% increase compared to the same month last year, indicating steady growth.

What is the source and date?

PR Times: https://openapi.twse.com.tw/revenue/twse-rev-4771-11503 | March 1, 2026

Back to Newsroom (52)